Because ERβ contributed to the upregulation of target genes mediated by CLPTM1L and was coactivated by CLPTM1L in NSCLC cells, we tested the effects of ERβ silencing or overexpression on CLPTM1L-modulated cell radiosensitivity. The gene discussed is CLPTM1L; the disease is non-small cell lung carcinoma.